Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacterial cell membrane and its associated biosynthetic machinery constitute a vital structural and functional complex essential for bacterial viability and pathogenesis (StatPearls: NBK459363). This target system includes the cytoplasmic phospholipid bilayer and the intricate enzymatic pathways responsible for synthesizing the thick, protective peptidoglycan layer characteristic of Gram-positive species. Key molecular components include penicillin-binding proteins (PBPs), which facilitate the final stages of cell wall cross-linking, and lipid intermediates like Lipid II that transport precursors across the membrane (Microbiology and Molecular Biology Reviews, 2008). In clinical practice, this machinery is the focal point for many of the most effective antibiotic classes, such as beta-lactams, glycopeptides, and lipopeptides. For instance, daptomycin targets the membrane directly by causing rapid depolarization and ion leakage (StatPearls: NBK470413), while vancomycin binds to the D-Ala-D-Ala terminus of peptidoglycan precursors to inhibit synthesis. Because these biosynthetic processes are absent in human cells, they provide a high degree of selective toxicity, although the rise of resistant strains like MRSA and VRE necessitates the ongoing development of next-generation inhibitors (Nature Reviews Microbiology, 2015).
Inhibition of peptidoglycan transpeptidation via PBP binding, sequestration of Lipid II to halt cell wall assembly, and calcium-dependent membrane depolarization leading to ion leakage (StatPearls: NBK470413, NBK459363).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-positive bacterial cell membrane and associated biosynthetic machinery.